1. Single photon emission computed tomography and transmission computed tomography in the evaluation of liver disease
- Author
-
Brunetti Jc, Van Heertum Rl, and Yudd Ap
- Subjects
Adult ,Male ,Lymphoma ,Autopsy ,Single-photon emission computed tomography ,Liver disease ,Multifocal disease ,Medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Aged ,Aged, 80 and over ,Transmission Computed Tomography ,medicine.diagnostic_test ,business.industry ,Liver Diseases ,Ultrasound ,Liver Neoplasms ,General Medicine ,Middle Aged ,medicine.disease ,Colonic Neoplasms ,Diffuse disease ,Disease category ,Female ,business ,Nuclear medicine ,Tomography, X-Ray Computed ,Tomography, Emission-Computed - Abstract
To assess the relative strengths of hepatic SPECT and transmission computed tomography (TCT), a comparison of these methods was made in 88 patients during a 20-month period. The scans were classified into four categories: normal, solitary focal, multifocal, or diffuse hepatocellular patterns. The final disease category was determined by histologic evaluation-biopsy/autopsy, surgery, or a combination of ultrasound, laboratory, and clinical follow-up for a minimum of 6 months. Both SPECT and TCT were normal in the 47 patients classified as normal. Of the 16 patients with diffuse hepatocellular disease, SPECT correctly identified 16 and TCT identified two patients. Eleven patients had solitary focal disease; 11 were detected by SPECT and 10 by TCT. Fourteen patients were in the multifocal disease group; 13 were detected by SPECT and 10 by TCT. Overall, SPECT and TCT findings were in agreement in 68 (77%) of the cases. This study demonstrates that SPECT is equal to TCT in the assessment of the liver parenchyma in normal and focal disease states and that SPECT is superior in the assessment of diffuse disease.
- Published
- 1988